Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis

Abstract Background With a suite of promising new RSV prophylactics on the horizon, including long-acting monoclonal antibodies and new vaccines, it is likely that one or more of these will replace the current monoclonal Palivizumab programme. However, choosing the optimal intervention programme wil...

Full description

Bibliographic Details
Main Authors: David Hodgson, Richard Pebody, Jasmina Panovska-Griffiths, Marc Baguelin, Katherine E. Atkins
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12916-020-01802-8